Antimicrobial resistance among community-acquired pneumonia isolates in Europe: First results from the SENTRY antimicrobial surveillance program 1997

International Journal of Infectious Diseases

Volumn 3, Issue 3, 1999, Pages 153-156

  Fluit, Ad C ^a,e   Schmitz, Franz Josef ^a   Jones, Mark E ^a   Acar, Jacques ^b   Gupta, Renu ^c   Verhoef, Jan ^a   Mittermayer, Helmut ^d   Struelens, Marc ^d   Goldsteift, Fred ^d   Jarlier, Vincent ^d   Etienne, Jerome ^d   Courcol, Rene ^d   Daschner, Franz ^d   Hadding, Ulrich ^d   Legakis, Nikos ^d   Schito, Gian Carlo ^d   Raponi, Gianmarco ^d   Heczko, Piotr ^d   Hymiewicz, Waleria ^d   Costa, Dario ^d   Perea, Evelio ^d   Baquero, Fernando ^d   Alvarez, Rogelio Martin ^d   Bille, Jacques ^d   French, Gary ^d   more..

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b SAINT JOSEPH HOSPITAL   (France)

^c BRISTOL MYERS SQUIBB   (United States)

^d NONE

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Antibiotic; Resistance; Surveillance

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFEPIME; CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; OFLOXACIN; PENICILLIN G; RIFAMPICIN; SPARFLOXACIN; TETRACYCLINE; TROVAFLOXACIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL PNEUMONIA; BACTERIUM ISOLATE; COMMUNICABLE DISEASE; CONTROLLED STUDY; EUROPE; HAEMOPHILUS INFLUENZAE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NONHUMAN; STREPTOCOCCUS PNEUMONIAE;

EID: 6544282773     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1201-9712(99)90037-1     Document Type: Article

References (14)

1. Turner-Warwick M, Hodson ME, Corrin B, Kerr IH. Clinical atlas of respiratory diseases London: Gower Medical Publishing, 1990.
2. Skudlarska BA, Scott GC. The role of antibiotics in the management of acute exacerbations of chronic bronchitis (answers to some commonly asked questions). Mol Med 1992; 89:289-293.
3. Ball P, Harris JM, Lowson D, Tillotson G, Wilson R. Acute infective exacerbations of chronic bronchitis. QJM 1995; 88:61-68.
4. Woodhead MA, Macfarlane JT, McCracken JS, Rose DH, Finch RG. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987; i:671-674.
5. Marston BJ, Plouffe JF, Breiman RF, et al. Preliminary findings of a community-based pneumonia incidence study. In: Breiman RF, Barbaree JM, Dufour AP, eds. Legionella. Proceedings of the Fourth International Symposium of the American Society for Microbiology, Washington, DC, 1993.
6. Research Committee of the British Thoracic Society and Public Health Laboratory Service. Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors, and outcome. QJM 1987; 62:193-220.
7. Pneumonia and influenza death rates: United States, 1979-1994. MMWR Morb Mortal Wkly Rep 1995; 44:535-537.
8. Richard MP, Gil Aguado A, Mattina R, Marre A, the SPAR Study Group. Sensitivity to sparfloxacin and other antibiotics of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis strains isolated from adult patients with community-acquired lower respiratory tract infections: a European multicentre study. J Antimicrob Chemother 1998; 41:207-214.
9. Felmingham D, Grüneberg RN, the Alexander Project Collaborative Group. A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: the Alexander Project. J Antimicrob Chemother 1996; 38 (Suppl A):1-57.
10. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Supplement tables. Wayne, PA: NCCLS, 1998:M100-S8.
11. Grüneberg RN, Felmingham D, the Alexander Project Group. Results of the Alexander Project: a continuing, multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens. Diagn Microbiol Infect Dis 1996; 25:169-181.
12. Jones RN, Cormican MG, Wanger A. Clindamycin resistance among erythromycin-resistant Streptococcus pneumoniae. Diagn Microbiol Infect Dis 1996; 25:201-204.
13. Geddes AM. Grepafloxacin-focus on respiratory infections. J Antimicrob Chemother 1997; 40 (Suppl A):1-4.
14. Grossman RF. The role of fluoroquinolones in respiratory tract infections. J Antimicrob Chemother 1997; 40 (Suppl A):59-62.